JP2013516194A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013516194A5 JP2013516194A5 JP2012548181A JP2012548181A JP2013516194A5 JP 2013516194 A5 JP2013516194 A5 JP 2013516194A5 JP 2012548181 A JP2012548181 A JP 2012548181A JP 2012548181 A JP2012548181 A JP 2012548181A JP 2013516194 A5 JP2013516194 A5 JP 2013516194A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- nucleic acid
- promoter
- transduced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29352210P | 2010-01-08 | 2010-01-08 | |
| US61/293,522 | 2010-01-08 | ||
| PCT/US2011/020578 WO2011085247A2 (en) | 2010-01-08 | 2011-01-07 | Vectors and methods for transducing b cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013516194A JP2013516194A (ja) | 2013-05-13 |
| JP2013516194A5 true JP2013516194A5 (cg-RX-API-DMAC7.html) | 2014-02-27 |
| JP5873807B2 JP5873807B2 (ja) | 2016-03-01 |
Family
ID=44306176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012548181A Active JP5873807B2 (ja) | 2010-01-08 | 2011-01-07 | B細胞を形質導入するためのベクターおよび方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9074223B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2521789B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5873807B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2786664C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2521789T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2617749T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011085247A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104080805B (zh) * | 2011-11-07 | 2017-02-22 | 美国政府健康及人类服务部 | gp41中和性抗体及其用途 |
| ES2786253T3 (es) * | 2013-03-14 | 2020-10-09 | Immusoft Corp | Métodos para la diferenciación y transducción in vitro de células b de memoria con vectores virales pseudotipados vsv-g |
| US20160075766A1 (en) | 2013-05-21 | 2016-03-17 | Roche Diagnostics Operations, Inc. | Method for producing antibodies using ovine b-cells and uses thereof |
| JP6568207B2 (ja) * | 2014-05-19 | 2019-08-28 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | ヒツジb細胞を用いて抗体を産生するための方法およびその使用 |
| EP4177336A1 (en) | 2014-12-19 | 2023-05-10 | Immusoft Corporation | B cells for in vivo delivery of therapeutic agents |
| CA2981077A1 (en) * | 2015-04-03 | 2016-10-06 | Dana-Farber Cancer Institute, Inc. | Composition and methods of genome editing of b-cells |
| EP3417052B1 (en) * | 2016-02-16 | 2023-02-15 | Duke University | Methods for expanding and differentiating b cells for producing antibody |
| JP2020517692A (ja) * | 2017-04-27 | 2020-06-18 | イミュソフト コーポレーション | 治療剤のin vivo送達のためのB細胞およびその投薬量 |
| CN119265240A (zh) * | 2017-10-20 | 2025-01-07 | 弗莱德哈钦森癌症中心 | 用以产生被遗传修饰来表达所选抗体的b细胞的系统和方法 |
| CA3093716A1 (en) | 2018-03-16 | 2019-09-19 | Immusoft Corporation | B cells genetically engineered to secrete follistatin and methods of using the same to treat follistatin-related diseases, conditions, disorders and to enhance muscle growth and strength |
| RU2714380C1 (ru) * | 2018-12-28 | 2020-02-14 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Способ получения цитотоксических т-лимфоцитов, экспрессирующих химерные рецепторы |
| CA3136551A1 (en) * | 2019-04-12 | 2020-10-15 | Board Of Regents, The University Of Texas System | Methods for producing regulatory b cells and uses thereof |
| WO2021154993A1 (en) * | 2020-01-28 | 2021-08-05 | University Of Southern California | Genome engineering the human immunoglobulin locus to express recombinant binding domain molecules |
| CA3192356A1 (en) * | 2020-08-17 | 2022-02-24 | Northwestern University | B-cell based immunotherapy for the treatment of glioblastoma and other cancers |
| US20250152714A1 (en) | 2023-11-15 | 2025-05-15 | Immusoft Corporation | Migratory modified differentiated b cells for cancer therapy |
| WO2025147573A2 (en) | 2024-01-05 | 2025-07-10 | Immusoft Corporation | Glp-1 expressing modified b cells for the treatment of metabolic disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| US6218181B1 (en) | 1998-03-18 | 2001-04-17 | The Salk Institute For Biological Studies | Retroviral packaging cell line |
| CA2413995C (en) | 2000-06-01 | 2013-08-13 | Dnavec Research Inc. | Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity |
| WO2003068819A1 (en) * | 2001-12-22 | 2003-08-21 | 4-Antibody Ag | Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins |
| US7632509B2 (en) * | 2005-07-19 | 2009-12-15 | Biosante Pharmaceuticals, Inc. | Methods to express recombinant proteins from lentiviral vectors |
| EP1975239A1 (en) | 2006-09-27 | 2008-10-01 | Bundesrepublik Deutschland, letztvertreten durch den Präsidenten des Paul-Ehrlich-Instituts Prof. Dr. Johannes Löwer | Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high-throughput screening |
| US8133727B2 (en) | 2008-11-21 | 2012-03-13 | California Institute Of Technology | In vitro human B lymphopoiesis culture system |
-
2011
- 2011-01-07 DK DK11732231.3T patent/DK2521789T3/en active
- 2011-01-07 EP EP11732231.3A patent/EP2521789B1/en active Active
- 2011-01-07 CA CA2786664A patent/CA2786664C/en active Active
- 2011-01-07 JP JP2012548181A patent/JP5873807B2/ja active Active
- 2011-01-07 US US13/520,921 patent/US9074223B2/en active Active
- 2011-01-07 WO PCT/US2011/020578 patent/WO2011085247A2/en not_active Ceased
- 2011-01-07 ES ES11732231.3T patent/ES2617749T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10829566B2 (en) | Method employing bispecific antibodies | |
| JP7264329B2 (ja) | T細胞療法を向上させるための、哺乳動物t細胞の活性化により誘導可能な合成プロモーター(syn+pro)の作製 | |
| WO2015155370A4 (en) | Group b adenovirus modified in the e4orf4 region | |
| JP2019508017A5 (cg-RX-API-DMAC7.html) | ||
| JP2016025858A5 (cg-RX-API-DMAC7.html) | ||
| JP2021534829A5 (cg-RX-API-DMAC7.html) | ||
| JP2019534036A5 (cg-RX-API-DMAC7.html) | ||
| JP2012504959A5 (cg-RX-API-DMAC7.html) | ||
| WO2011085247A4 (en) | Vectors and methods for transducing b cells | |
| CN120513099A (zh) | 巨噬细胞特异性启动子和其用途 | |
| JP2024515263A5 (cg-RX-API-DMAC7.html) | ||
| US20230100000A1 (en) | Immune cell expressing adapter chimeric antigen receptor for sensing soluble antigens | |
| CN109306340B (zh) | 一种高效扩增全t细胞的人工抗原递呈细胞及其用途 | |
| JP2025118760A (ja) | 細胞の選択方法 | |
| JP2023532665A (ja) | 核酸の標的化組み込み | |
| JP2024533328A (ja) | 誘導性プロモーター、それに基づくベクターおよび宿主細胞 | |
| CN112458116B (zh) | 一种pd-1敲除的cd19car-t细胞的构建方法 | |
| US20240415891A1 (en) | Activation responsive promoters and uses thereof | |
| JP2026511057A (ja) | Ccl20プロモーター調節遺伝子発現 | |
| TW202544250A (zh) | 巨噬細胞特異性啟動子及其用途 | |
| TW202400789A (zh) | Eno1基因的啟動子 | |
| WO2025084267A1 (ja) | 形質転換体及び目的タンパク質の生産方法 | |
| KR20260035834A (ko) | 개선된 다중시스트론성 시스템 및 이의 용도 | |
| CN121986170A (zh) | 工程化调控元件 | |
| HK40113432A (en) | Inducible promoter, vector and host cell based thereon |